198 related articles for article (PubMed ID: 32832624)
1. RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma.
Jiao F; Li Z; He C; Xu W; Yang G; Liu T; Shen H; Cai J; Anastas JN; Mao Y; Yu Y; Lan F; Shi YG; Jones C; Xu Y; Baker SJ; Shi Y; Guo R
Sci Adv; 2020 Jul; 6(29):eaba2113. PubMed ID: 32832624
[TBL] [Abstract][Full Text] [Related]
2. Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.
Sweha SR; Chung C; Natarajan SK; Panwalkar P; Pun M; Ghali A; Bayliss J; Pratt D; Shankar A; Ravikumar V; Rao A; Cieslik M; Wilder-Romans K; Scott AJ; Wahl DR; Jessa S; Kleinman CL; Jabado N; Mackay A; Jones C; Martinez D; Santi M; Judkins AR; Yadav VN; Qin T; Phoenix TN; Koschmann CJ; Baker SJ; Chinnaiyan AM; Venneti S
Sci Transl Med; 2021 Oct; 13(615):eabf7860. PubMed ID: 34644147
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma.
Funato K; Smith RC; Saito Y; Tabar V
Cell Stem Cell; 2021 May; 28(5):894-905.e7. PubMed ID: 33631117
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
Zika E; Greer SF; Zhu XS; Ting JP
Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
[TBL] [Abstract][Full Text] [Related]
5. Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of
Abdallah AS; Cardona HJ; Gadd SL; Brat DJ; Powla PP; Alruwalli WS; Shen C; Picketts DJ; Li XN; Becher OJ
Neurooncol Adv; 2023; 5(1):vdad003. PubMed ID: 36845293
[TBL] [Abstract][Full Text] [Related]
6. Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies.
Voon HPJ; Hii L; Garvie A; Udugama M; Krug B; Russo C; Chüeh AC; Daly RJ; Morey A; Bell TDM; Turner SJ; Rosenbluh J; Daniel P; Firestein R; Mann JR; Collas P; Jabado N; Wong LH
Genome Biol; 2023 Dec; 24(1):284. PubMed ID: 38066546
[TBL] [Abstract][Full Text] [Related]
7. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
8. A lesson learned from the H3.3K27M mutation found in pediatric glioma: a new approach to the study of the function of histone modifications in vivo?
Chan KM; Han J; Fang D; Gan H; Zhang Z
Cell Cycle; 2013 Aug; 12(16):2546-52. PubMed ID: 23907119
[TBL] [Abstract][Full Text] [Related]
9. Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.
Yotsumoto K; Sanui T; Tanaka U; Yamato H; Alshargabi R; Shinjo T; Nakao Y; Watanabe Y; Hayashi C; Taketomi T; Fukuda T; Nishimura F
Front Immunol; 2020; 11():709. PubMed ID: 32373130
[TBL] [Abstract][Full Text] [Related]
10. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
11. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
[TBL] [Abstract][Full Text] [Related]
12. TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia.
Qian J; Luo F; Yang J; Liu J; Liu R; Wang L; Wang C; Deng Y; Lu Z; Wang Y; Lu M; Wang JY; Chu Y
Cancer Immunol Res; 2018 Oct; 6(10):1220-1233. PubMed ID: 30131377
[TBL] [Abstract][Full Text] [Related]
13. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter.
Adamski J; Ma Z; Nozell S; Benveniste EN
Mol Endocrinol; 2004 Aug; 18(8):1963-74. PubMed ID: 15143155
[TBL] [Abstract][Full Text] [Related]
14. [Mutations in histone H3.3 and chromatin remodeling genes drive pediatric and young adult glioblastomas].
Khuong-Quang DA; Gerges N; Jabado N
Med Sci (Paris); 2012 Oct; 28(10):809-12. PubMed ID: 23067407
[No Abstract] [Full Text] [Related]
15. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.
Kasuga Y; Ouda R; Watanabe M; Sun X; Kimura M; Hatakeyama S; Kobayashi KS
Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2218955120. PubMed ID: 37279268
[TBL] [Abstract][Full Text] [Related]
16. ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes.
Li N; Li Y; Lv J; Zheng X; Wen H; Shen H; Zhu G; Chen TY; Dhar SS; Kan PY; Wang Z; Shiekhattar R; Shi X; Lan F; Chen K; Li W; Li H; Lee MG
Mol Cell; 2016 Aug; 63(3):470-84. PubMed ID: 27477906
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.
Voon HPJ; Udugama M; Lin W; Hii L; Law RHP; Steer DL; Das PP; Mann JR; Wong LH
Nat Commun; 2018 Aug; 9(1):3142. PubMed ID: 30087349
[TBL] [Abstract][Full Text] [Related]
18. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Schwartzentruber J; Korshunov A; Liu XY; Jones DT; Pfaff E; Jacob K; Sturm D; Fontebasso AM; Quang DA; Tönjes M; Hovestadt V; Albrecht S; Kool M; Nantel A; Konermann C; Lindroth A; Jäger N; Rausch T; Ryzhova M; Korbel JO; Hielscher T; Hauser P; Garami M; Klekner A; Bognar L; Ebinger M; Schuhmann MU; Scheurlen W; Pekrun A; Frühwald MC; Roggendorf W; Kramm C; Dürken M; Atkinson J; Lepage P; Montpetit A; Zakrzewska M; Zakrzewski K; Liberski PP; Dong Z; Siegel P; Kulozik AE; Zapatka M; Guha A; Malkin D; Felsberg J; Reifenberger G; von Deimling A; Ichimura K; Collins VP; Witt H; Milde T; Witt O; Zhang C; Castelo-Branco P; Lichter P; Faury D; Tabori U; Plass C; Majewski J; Pfister SM; Jabado N
Nature; 2012 Jan; 482(7384):226-31. PubMed ID: 22286061
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
20. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription.
Fan Z; Kong X; Xia J; Wu X; Li H; Xu H; Fang M; Xu Y
Biochim Biophys Acta; 2016 May; 1859(5):687-96. PubMed ID: 26972221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]